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Protocol
========

1. HO-stimulated translocation frequencies
------------------------------------------

1.  Inoculate 10-20 independent 1 ml cultures of YPGly/Lac medium (1% yeast extract, 2% peptone, 3% glycerol and 3% lactate) with single colonies of the desired genotype. Incubate the cultures overnight, or for sufficient time to reach a cell density of approximately 5x10^7^-1x10^8^ cell/ml, at 30°C on a rotator, or with gentle agitation.

2.  Add galactose to the cultures to a final concentration of 2% to induce HO endonuclease-directed DSBs at the *his3-Δ3\'* (chromosome III) and *his3-Δ5\'* (chromosome XV) translocation substrates.

3.  Incubate for 4 h at 30°C on a rotator, or with gentle agitation.

4.  After 4 h, plate appropriate dilutions of the cultures onto YPD (1% yeast extract, 2% peptone, 2% dextrose) to yield approximately 100 to 200 colonies per plate, and a sufficient number of cells onto medium lacking histidine to yield an observable number of His^+^ recombinant colonies. Incubate plates at 30°C for two to three days.

*NOTE:* Step 1.4 describes the determination of translocation frequencies under selective conditions by plating the cultures onto medium lacking histidine. This assay can also be conducted under non-selective conditions by plating cultures onto YPD, and then replica-plating the colonies that arise onto --His plates two to three days later. These methods produce similar frequencies of translocation (**Figure 2C**).

1.  Determine the translocation frequency by dividing the number of histidine prototrophic colonies by the total number of viable cells plated (determined by plating dilutions on YPD). Determine the median translocation frequency and 95% confidence interval^15^.

2. Plating efficiencies
-----------------------

1.  Remove an aliquot of cells from each overnight culture, and determine cell number by hemacytometer count (Baxter Healthcare Corporation. Catolog \#: B3178-1).

2.  Plate approximately 100 to 200 cells using an appropriate dilution onto YPD. Incubate for two to three days at 30°C (*e.g.* For a culture with a cell density of 1x10^8^ cells/ml, one should plate 100-200 μl of a 10-5 dilution per plate).

3.  Add 20% galactose to the cultures to a final concentration of 2%.

4.  After 4 h, remove an aliquot of cells from each culture, determine cell number by hemacytometer count, and plate approximately 100 to 200 cells using an appropriate dilution onto YPD. Incubate for two to three days at 30°C.

5.  Determine the plating efficiency by dividing the number of colonies appearing on YPD by the number of cells plated, and multiplying this quotient by 100. Determine the median percentage with a 95% confidence interval.

3. Genomic Southern blot analysis
---------------------------------

1.  Select a single His^+^ recombinant colony from each independent trial and prepare genomic DNA^16^.

2.  Digest approximately 4 μg of DNA with BamHI restriction endonuclease.

3.  Separate BamHI digested fragments on a 0.7% agarose gel, and transfer to a positively-charged nylon membrane (Hybond N^+^, GE Healthcare. Product Code: RPN303B)^17^.

4.  Hybridize with a ^32^P-labeled probe obtained by random priming (Amersham Biosciences. Product Code: RPN1604) with a 1.8 kb BamHI/BamHI genomic clone containing the *HIS3* gene.

5.  Visualize DNA fragments by autoradiography or phosphorimaging.

4. Chromosome blot analysis using chromosomes separated in a contour-clamped homogeneous electric field (CHEF):
---------------------------------------------------------------------------------------------------------------

1.  Prepare chromosomes from selected His^+^ recombinants in agarose plugs^18^: Grow a liquid culture of the His^+^ candidate tXV::III chromosome-containing recombinant in 5 ml of YPD to approximately 1-2 x 10^8^ cell/ml.Spin down and wash the cells 2 times with 50 mM EDTA.Resuspend cells in approximately 200 μl of 50 mM EDTA, and warm to 50°C.Add an equal volume of molten 2% (w/v) low melt agarose brought to 50°C, mix thoroughly.Dispense approximately 80 μl aliquots into plug molds, and allow them to cool for 30 min at 4°C.Extrude plugs from the mold into a 12-well dish. Up to five plugs can be placed into each well.Add 3 ml of freshly prepared spheroplasting solution (14 mM 2-β-mercaptoethanol, 20 mM EDTA, 0.5 mg/ml Zymolyase 20T, 10 mM Tris-HCl, pH 7.5, 1 M Sorbitol) to each well. Incubate at 37°C for 4 hours with gentle agitation.Remove spheroplasting solution and replace with 3 ml of LDS solution (10 mM Tris-HCl, pH 8.0, 100 mM EDTA, 1% (w/v) Lithium Dodecyl Sulfate, adjust pH to 8.0). Incubate at 37°C for 15 min with gentle agitation.Remove LDS solution and replace with another 3 ml aliquot of LDS. Incubate at 37°C overnight with gentle agitation.Remove LDS and replace with 3 ml of 0.2 X NDS (0.6 g Tris Base, 93 g Disodium EDTA Dihydrate, 5 g N-Lauroyl Sarcosine, adjust pH to 8.0, brought to 500 ml with dH~2~O). Incubate at room temperature for 30 min with gentle agitation. Remove NDS, and repeat 2 times.Remove NDS and replace with 3 ml TE. Wash with gentle agitation for 30 min at room temperature. Repeat 4 times.Store plugs at 4°C in 2 ml of TE. Plugs can keep for up to a year.

2.  Separate chromosomes on a 1% agarose gel using a Bio-Rad CHEF-DRII apparatus at 14°C (Catalog \#: 170-3612).

*Parameters:* 1^st^ Block: 70s switch time, 15h at 6V/cm. 2^nd^ Block: 120s switch time, 11h at 6V/cm

1.  Visualize chromosomes by staining with 1μg/ml ethidium bromide for 30 min, irradiating with 60 mJ of UV in a UV Stratalinker (Stratagene), and de-staining for 30 min in dH~2~O. Irradiating ethidium bromide stained chromosomes nicks the DNA to allow for efficient transfer to the membrane.

2.  Transfer chromosomes to a positively charged membrane (Hybond N+, GE Healthcare. Product Code: RPN303B) by capillary action in denaturing conditions (0.4N NaOH, 1.5M NaCl).

3.  Hybridize with a ^32^P-labeled probe obtained by random priming (Amersham Biosciences. Product Code: RPN1604) with a 1.8 kb BamHI/BamHI genomic clone containing the *HIS3* gene^17^.

4.  Visualize chromosomes by autoradiography or phosphorimaging.

5. Representative Results:
--------------------------

A graphical representation of the translocation assay is depicted at the chromosomal level (**Figure 1**). A schematic of the experimental procedure is also displayed (**Figure 2A**). Both pre- and post-induction plating efficiencies are determined by dividing the total number of viable, colony forming cells by the total number of cell bodies in the culture determined by hemacytometer count (**Figure 4B**). Pre- and post-induction plating efficiencies were not significantly different for wild-type cells (p-value= 0.1400) (**Table 1**).

**Table 1. Pre- and post-induction plating efficiencies in wild-type cells.**

^a^ The number of cell bodies per milliliter are determined by hemacytometer count. ^b^ The number of viable cells per milliliter are determined by plating appropriate dilutions onto non-selective medium to produce ˜100-200 colonies. ^c^The pre- and post-induction plating efficiencies are determined by dividing the total number of viable, colony forming, cells by the total number of cell bodies in the culture, determined by hemacytometer count.

This suggests that the presence or absence of either translocation chromosome does not affect the ability to survive DSB formation. The frequency of chromosomal translocations can be calculated by dividing the number of histidine prototrophic colonies by the total number of viable cells determined by plating onto YPD (**Figure 2B**). This assay can be conducted using strains of different genotype to identify how loss of protein function affects SSA (*i.e. rad51Δ^-/-^*). Recombination frequencies determined in different strains can then be graphed to compare differences in the ability of these strains to repair the HO-endonuclease induced DSBs by SSA (**Figure 2C**). Translocation frequencies obtained with the wild-type diploid strain under selective (2.2x10^-2^) and non-selective (2.17x10^-2^) conditions were not statistically different from each other (p-value= 0.9131), while the translocation frequencies obtained selectively (6.0x10^-2^) and non-selectively (11.9x10^-2^) with the *rad51Δ^-/-^* homozygote were similar but statistically different (p-value= 0.0089). The frequencies obtained both selectively (p-value=0.0001) and non-selectively (p-value=0.0002) with the *rad51°^-/-^* homozygote were statistically different from those obtained using the corresponding conditions with the wild-type strain.

Putative translocation-bearing clones can be further examined by genomic Southern blot and chromosomal blot analyses (**Figure 3**). For Southern analysis, genomic DNA is digested with BamHI endonuclease prior to agarose gel electrophoresis, blotting and hybridization to a ^32^P-labeled 1.8kb *HIS3* probe to visualize the diagnostic 0.8 kb *his3Δ200*, 1.7 kb *his3-Δ3\'*, 4 kb tIII::XV, 5 kb tXV::III, and 8 kb *his3-Δ5\'* fragments (**Figure 3B.1**). Intact chromosomes can be prepared, separated by CHEF (**Figure 3B.2**), blotted to nylon and hybridized with the ^32^P-labeled 1.8 kb *HIS3* probe to visualize the 1.1 Mb intact chromosome XV, 0.8 Mb tXV:III translocation chromosome, 0.6 Mb tIII:XV translocation chromosome, and 0.3 Mb intact chromosome III (**Figure 3B.3**). A graphical map depicting expected BamHI endonuclease-digested genomic DNA fragments, and parent and recombinant chromosomes, is depicted (**Figure 3A**).

**Figure 1. Formation of translocation chromosomes by single-strand annealing (SSA).** 1) DSBs are created at the *his3-Δ3\'* and *his3-Δ5\'* substrates (chromosomes XV and III, respectively) by HO endonuclease following the addition of galactose to the cultures. 2) DSBs are processed to generate 3\' single-strands at the ends of the broken chromosomes. 3) SSA machinery anneals complementary 311 or 60 nucleotide single-stranded *HIS3* sequences formed at each of the recombination substrates. Non-homologous tails formed upon annealing are removed by endonuclease digestion. Complementary four bp overhangs on the remaining chromosomal fragments formed by HO-endonuclease digestion may also anneal. 4) Ligation concludes the creation of an intact *HIS3* gene and tXV::III translocation chromosome by SSA. Cells carrying this chromosome can be selected for by their ability to grow on medium lacking histidine. Ligation may also generate the reciprocal tIII::XV translocation chromosome by a NHEJ-like mechanism.

**Figure 2. Assay for determining the frequency of translocation by SSA.** A) One ml YPGly/Lac cultures are inoculated with single colonies of cells of a select genotype and grown to an appropriate density of approximately 5x10^7^-1x10^8^ cell/ml. Galactose is added to a final concentration of 2% to create DSBs at the recombination substrates on chromosomes III and XV. To conduct the assay under selective conditions, appropriate dilutions are made such that approximately 100 to 200 cells are plated onto YPD and a sufficient number of cells are plated onto medium lacking histidine to yield an observable number of His^+^ recombinant colonies. To conduct the assay without selection, approximately 100 to 200 cells are plated onto YPD, grown for two to three days to single colonies and then replica plated onto medium lacking histidine. B) Translocation frequency can be determined by dividing the number of colonies that grow on --His plates by the fraction that grow on YPD. C) The translocation frequencies of strains of different genotype (*i.e.* Wild-type and *rad51Δ^-/-^*) can be graphed to compare differences in the ability of these strains to repair the DSBs by SSA.

**Figure 3. Determining plating efficiency.** (A) An aliquot of cells is taken from the overnight culture prior to and post DSB induction, appropriate dilutions are made, followed by a hemacytometer count to determine the total number of cell bodies per ml of culture. Appropriate dilutions are plated onto non-selective medium to determine the total number of viable cells per ml, by counting the colonies that appear on YPD. (B) The plating efficiency is then determined by dividing the total number of viable cells by the total number of cell bodies, and multiplying this quotient by 100.

**Figure 4. Detection of chromosomal translocation events by genomic Southern blot and chromosome blot analyses.***A) Graphical representation of relevant chromosomes before (left) and after (right) translocation formation.* Sizes of parent and recombinant chromosomes are listed in megabase-pairs (Mb). Sizes of restriction fragments containing relevant sequences generated by BamHI digestion of genomic DNA from parent and recombinant strains, and revealed on blots by hybridization with a 1.8 kb BamHI *HIS3* genomic clone, are listed in kilobase-pairs (kb). Chromosomes are not drawn to scale. *B) Physical analysis of putative translocation-bearing clones.* (1) Genomic Southern blot analysis -- Genomic DNA was collected and digested with BamHI restriction endonuclease, fractionated by gel electrophoresis, blotted to nylon, and hybridized to a ^32^P-labeled 1.8 kb *HIS3* probe to visualize the following fragments: 0.8 kb *his3Δ200*, 1.7 kb *his3-Δ3\'*, 4 kb tIII::XV, 5 kb tXV::III , and 8 kb *his3-Δ5\'*. Lanes: a) parent diploid, b) His^+^ non-reciprocal translocation recombinant, c) His^+^ reciprocal translocation recombinant. (2) CHEF gels - Intact chromosomes were prepared in agarose plugs, separated by CHEF, stained with ethidium bromide and visualized under UV light. Lanes: As above. (3) Chromosome blots -- Separated chromosomes were blotted to nylon and hybridized with the ^32^P-labeled 1.8 kb *HIS3* probe to visualize the following chromosomes: 1.1 Mb intact chromosome XV, 0.8 Mb tXV:III translocation chromosome, 0.6 Mb tIII:XV translocation chromosome, and 0.3 Mb intact chromosome III. Lanes: As above.

Discussion
==========

High doses of ionizing radiation present an inherent risk of genome instability through the generation of a large number of DSBs^19^. Eukaryotic genomes are replete with repetitive sequences that are excellent substrates for generating translocations and other genomic rearrangements^20,21^. Chromosomal translocations by HR are frequently observed when DSBs are introduced between repetitive sequences^12,21,22^. Overwhelming evidence suggests that much of the genomic instability associated with leukemias and lymphomas can be attributed to chromosomal translocations, highlighting the importance of understanding how this mechanism occurs in eukaryotes^22,23^. We have developed a system in budding yeast for examining the formation of translocation chromosomes by DSB-induced HR between short regions of homology on different chromosomes that are similar in size to repetitive elements dispersed throughout the yeast and human genomes.

In the assay, the *his3-Δ3\'* translocation substrate is located on one copy of chromosome XV. The other *his3* allele (*his3-Δ200*) has a \~1kb deletion of the *HIS3* promoter and coding sequence that prevents this sequence from being used as a template for repair^24^. The *his3-Δ5\'* substrate is located at the *LEU2* locus on one copy of chromosome III, with the other copy of chromosome III containing an unaltered *LEU2* allele (**Figure 1**). A galactose-inducible HO endonuclease expression cassette marked with *KAN-MX* was inserted into the *TRP1* locus of chromosome IV (*trp1::GAL-HO-KAN-MX*). Each translocation substrate is flanked by a HO-endonuclease recognition sequence that can be targeted for cleavage by inducing expression of the *HO* gene through the addition of galactose to the medium. After HO-endonuclease induced cleavage at the *his3-Δ3\'* and *his3-Δ5\'* substrates, cells can efficiently use the shared short tract of *HIS3* sequence homology (311 bp or 60 bp) to repair the broken chromosomes by HR, generating a translocation chromosome with an intact *HIS3* allele^12-14,25^.

Because the parent cells lack an intact copy of the *HIS3* gene, they are unable to grow on --His medium. Only cells that have undergone the translocation event can be selected for on medium lacking histidine. Therefore, the frequency of chromosomal translocations can be calculated by dividing the number of histidine prototrophic colonies by the total number of viable cells plated, determined by plating onto YPD. Genomic DNA and intact chromosomes can then be isolated from representative His^+^ colonies, and the presence of a translocation chromosome verified by genomic Southern and chromosome blot analyses.

Careful analysis has allowed us to gather additional important information about the assay^12^. Genomic Southern blot analysis has provided evidence that there is virtually complete cutting of chromosomes XV and III after 30 minutes of HO-endonuclease induction, and thus there is no significant background of uncut chromosomal substrates in the population (G. Manthey & A. Bailis, unpublished results). Genomic Southern and chromosome blot analyses of His^-^ survivors indicates that cells frequently lose one, the other, or both cut chromosomes and remain viable (L. Liddell & A. Bailis, unpublished results). Importantly, the nearly equivalent plating efficiencies on non-selective medium before and after induction of expression of HO-endonuclease indicates that neither the failure to repair broken chromosomes, nor the failure to retain translocation chromosomes affects the ability to survive DSB formation. Consistent with this, the tXV:III translocation chromosome has been shown to be unstable in mitotic cells in the absence of selection. This was demonstrated by growing tXV::III containing His^+^ recombinants overnight non-selectively, plating single colonies onto non-selective plates, and replica plating onto selective medium lacking histidine. Ten to 70% of the colonies arising on these plates had lost the tXV::III translocation chromosome (N. Pannunzio & A. Bailis, unpublished results).

Translocation chromosomes generated by IR exposure in humans exhibit a similar instability^26^. This suggests that translocation formation may contribute to early events in tumorigenesis by promoting loss of heterozygosity. Second, extensive genetic and molecular analyses suggest that SSA, an efficient and obligatorily non-conservative mechanism of HR, is the primary mechanism of translocation formation by HR following the simultaneous creation of DSBs on two chromosomes^12,27,28^. This is consistent with the finding that large doses of IR result in a density of DSBs sufficient to create breaks adjacent to multiple repetitive sequences in the yeast genome, and a high frequency of translocation formation by HR. Together, these observations suggest that the oncogenic effect of IR exposure in humans may, in part, result from the repair of DSBs by an efficient mechanism of HR that generates translocations that, through their inherent instability, promote genetic changes that launch tumorigenesis. Because radiation is often used to treat cancer, genome rearrangements that result from repair of radiation-induced DSBs may contribute to the generation of secondary cancers that arise frequently in patients. Thus, this model may help us gain a better understanding of the genetic and molecular basis of an important clinical response to IR treatment.
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